Clinical Trials Browser

Phase 2 × Liver Diseases × Ramucirumab × Clear all

NCT00627042 2014-10-08

Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy

Phase 2 Completed

42 enrolled 19 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms